Skip to main content
NVDA-2.44%AAPL+3.24%GOOGL+0.55%MSFT-0.20%AMZN-0.32%TSM-1.42%SPCX+0.09%AVGO-0.80%META-1.39%TSLA-1.01%SKHY-4.37%MU-4.58%BRK-B-0.28%LLY+0.08%JPM-0.64%WMT-0.10%AMD-3.13%V-0.21%XOM+0.76%ASMLa-1.66%JNJ-0.14%INTC-4.99%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-4.29%ABBV+0.98%BAC-0.42%CSCO-1.23%CVX-0.38%COST-0.19%KO+0.61%LRCX-5.20%CAT-1.51%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.86%HSBA.L-1.30%DELL-3.72%PG+0.35%MS-1.02%GE-0.79%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.95%0939.HK+1.66%GS-1.23%NZDJPY-2.66%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.49%EURNZD+1.46%NZDUSD-1.45%GBPNZD+1.40%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.08%USDZAR+1.03%USDNOK+0.90%USDSEK+0.89%EURZAR+0.85%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%AUDCAD-0.72%EURSEK+0.71%USDTHB+0.70%AUDDKK-0.67%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.60%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.55%USDMXN+0.54%USDPLN+0.45%NZDSGD-0.45%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.40%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.27%AUDCHF-0.26%SGDJPY+0.22%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.10%EURCNH-0.06%EURCAD-0.06%EURCZK-0.06%PLNJPY+0.06%CHFSGD-0.05%AUDNOK+0.05%EURGBP+0.04%USDCOP-0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.12%UKOIL+5.48%USOIL+5.36%GAGUSD-5.33%XAGUSD-5.33%HG1-4.92%GAUUSD-1.77%XAUUSD-1.77%XNGUSD+1.54%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.50%ETHUSD-0.17%USDTUSD-0.02%XRPUSD-3.00%SOLUSD-1.73%TRXUSDT+0.18%ZECUSDT-9.29%DOGEUSD-2.66%XMRUSDT+0.71%LINKUSD-1.47%XLMUSD-1.49%BCHUSDT-9.99%LTCUSD-1.64%UNIUSD-1.62%TONUSD+24.88%HBARUSDT-2.37%SUIUSD-4.41%TAOUSDT-5.69%AAVEUSD-2.48%DOTUSDT-1.83%ICPUSDT-0.90%ONDOUSDT-3.34%WLDUSDT-3.15%ATOMUSDT-3.30%ARBUSDT-1.05%JUPUSDT-3.39%INJUSDT-2.73%STXUSDT-4.53%FETUSDT-2.92%TIAUSDT-1.13%PYTHUSDT-1.65%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.79%WIFUSDT-5.38%OPUSDT-4.00%POLUSDT-4.47%IOTAUSDT-3.99%AXSUSDT-2.57%FARTCOINUSDT-2.79%EOSUSDT-2.78%DYDXUSDT-2.44%ORDIUSDT-1.04%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.44%AAPL+3.24%GOOGL+0.55%MSFT-0.20%AMZN-0.32%TSM-1.42%SPCX+0.09%AVGO-0.80%META-1.39%TSLA-1.01%SKHY-4.37%MU-4.58%BRK-B-0.28%LLY+0.08%JPM-0.64%WMT-0.10%AMD-3.13%V-0.21%XOM+0.76%ASMLa-1.66%JNJ-0.14%INTC-4.99%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-4.29%ABBV+0.98%BAC-0.42%CSCO-1.23%CVX-0.38%COST-0.19%KO+0.61%LRCX-5.20%CAT-1.51%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.86%HSBA.L-1.30%DELL-3.72%PG+0.35%MS-1.02%GE-0.79%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.95%0939.HK+1.66%GS-1.23%NZDJPY-2.66%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.49%EURNZD+1.46%NZDUSD-1.45%GBPNZD+1.40%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.08%USDZAR+1.03%USDNOK+0.90%USDSEK+0.89%EURZAR+0.85%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%AUDCAD-0.72%EURSEK+0.71%USDTHB+0.70%AUDDKK-0.67%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.60%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.55%USDMXN+0.54%USDPLN+0.45%NZDSGD-0.45%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.40%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.27%AUDCHF-0.26%SGDJPY+0.22%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.10%EURCNH-0.06%EURCAD-0.06%EURCZK-0.06%PLNJPY+0.06%CHFSGD-0.05%AUDNOK+0.05%EURGBP+0.04%USDCOP-0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.12%UKOIL+5.48%USOIL+5.36%GAGUSD-5.33%XAGUSD-5.33%HG1-4.92%GAUUSD-1.77%XAUUSD-1.77%XNGUSD+1.54%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.50%ETHUSD-0.17%USDTUSD-0.02%XRPUSD-3.00%SOLUSD-1.73%TRXUSDT+0.18%ZECUSDT-9.29%DOGEUSD-2.66%XMRUSDT+0.71%LINKUSD-1.47%XLMUSD-1.49%BCHUSDT-9.99%LTCUSD-1.64%UNIUSD-1.62%TONUSD+24.88%HBARUSDT-2.37%SUIUSD-4.41%TAOUSDT-5.69%AAVEUSD-2.48%DOTUSDT-1.83%ICPUSDT-0.90%ONDOUSDT-3.34%WLDUSDT-3.15%ATOMUSDT-3.30%ARBUSDT-1.05%JUPUSDT-3.39%INJUSDT-2.73%STXUSDT-4.53%FETUSDT-2.92%TIAUSDT-1.13%PYTHUSDT-1.65%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.79%WIFUSDT-5.38%OPUSDT-4.00%POLUSDT-4.47%IOTAUSDT-3.99%AXSUSDT-2.57%FARTCOINUSDT-2.79%EOSUSDT-2.78%DYDXUSDT-2.44%ORDIUSDT-1.04%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
HB

Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ • Healthcare

$41.62
-$0.45 (-1.1%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$42.01
Previous Close$41.62
Day Range$41.23 - $42.41
Avg. Volume (3M)734.8K
Market Cap$2.3B
P/E Ratio13.3
52 Week Range
$25.52$43.49
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$261.2M100%
Gross Profitminus cost of goods$198M76%
Operating Incomeminus R&D and overhead$89.3M34%
Net Incomeminus taxes and the rest$75.4M29%

In plain terms: out of every $100 in revenue, Harmony Biosciences Holdings, Inc. keeps $29 as net profit.

Fundamentals & Financials

Revenue (TTM)
$959.8M
Net Income (TTM)
$181.2M
EPS (TTM)
$3.13
ROA (TTM)
13.2%
Current Ratio
3.48
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-54.8%Q1 2026$0.38
-27.6%Q2 2026$0.55
+33.9%Q3 2026$1.28
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. develops and markets therapies for rare neurological conditions as a commercial-stage biotechnology company listed on the NASDAQ Global Market under the ticker HRMY. Its business today is centered on WAKIX in the United States, and it generated $868.5 million of revenue in FY2025.

Name
Harmony Biosciences Holdings, Inc.
CEO
Jeffrey Dayno
Website
www.harmonybiosciences.com
Industry
Healthcare
Year Founded
2017
Employees
293

Today's Snapshot

AI-generated

HRMY is trading 1.6% lower at 40.97, in line with a weaker sector. Harmony Biosciences outlined a broader growth plan at an investor conference.

Trading Volume

Below 10d avg (871.0K)

334.3K

vs S&P 500 Today

Underperforming Market

-0.95%

Updated: September 10, 2026 at 19:17 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
HRMY presents a bullish technical profile driven by a strong ADX that indicates a robust trend and a positive MACD complemented by constructive medium- and long-term moving averages well below price. Short-term averages are marginally above the current print and VWAP, suggesting a pause, but momentum readings remain positive and RSI is neutral-to-favorable. Volatility is moderate and the OBV is negative, which tempers the signal by highlighting lighter underlying volume. Technical takeaway: strong buy — trend strength and bullish momentum across key averages support the constructive bias despite mixed volume signals.
All signals
  • EMA (5 indicators)$34.64 - $41.08
    Buy
  • RSI (14)57.48
    Neutral
  • Stochastic %K (14, 3, 3)67.83
    Neutral
  • MACD Level (12, 26)1.19
    Buy

Peers & Related Assets

CLDXCelldex Therapeutics, Inc.
$38.78-0.9%
VERAVera Therapeutics, Inc.
$33.78-4.3%
NUVBNuvation Bio Inc.
$6.52-1.4%
AUPHAurinia Pharmaceuticals Inc.
$16.25+1.1%
BHVNBiohaven Ltd.
$15+1.9%
MNKDMannKind Corporation
$3.94-5.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.